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Abstract 
Background: Cochlear implants have been used for almost 30 years as a device for the rehabilitation of individuals 
with severe-to-profound hearing loss. One of the important aspects of cochlear implantation is the type of electrode 
selected and proper insertion of the electrode array in scala tympani to minimize cochlear damage. The HiFocus 
Helix™ electrode is a precurved design aimed at placing the electrode contacts close to the spiral ganglion cells in the 
modiolus. The prescribed insertion techniques are intended to minimize the likelihood of damage to the basilar mem-
brane or lateral wall of the cochlea.
Case presentation: To describe the first insertion of a HiFocus Helix™ electrode in Brazil exposing surgical particulari-
ties and device details in a patient with profound hearing loss, due to Mondini’s dysplasia.
Conclusion: No problems were encountered during the surgical procedure. The patient experienced improvement 
in hearing thresholds and speech perception. The HiFocus Helix™ electrode proved easy to insert and provided 
expected hearing benefits for the patient. This manuscript indicates that the HiResolution™ Bionic Ear System with 
HiFocus Helix™ electrode comprise a cochlear implant system that is practical and beneficial for the treatment of 
severe-to-profound hearing loss.
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Background
Cochlear implants are surgically implanted devices that 
provide hearing sensation to individuals with severe-to-
profound hearing loss who obtain limited benefit from 
hearing aids. By electrically stimulating the auditory 
nerve directly, a cochlear implant bypasses damaged or 
undeveloped sensory structures in the cochlea, thereby 
providing usable information about sound to the central 
auditory nervous system. Over the last 30 years, cochlear 
implants have become standard treatment for adults and 
children with severe-to-profound profound bilateral sen-
sorineural hearing loss.
In particular, hearing impairment in very young chil-
dren has a significant impact on both language and social 
development. The prevalence of congenital hearing loss 
varies from 1.2 to 2.7 per 1,000 newborns. Recent infor-
mation estimates a current rate of 1.4 per 1,000 new-
borns in the United States, which makes it the most 
frequent sensory deficit present at birth [1]. Fortunately 
for these young children, cochlear implants can provide 
the opportunity to develop hearing and speech abilities 
that is close to peers with normal hearing [2].
One of the important components of a cochlear-
implant system is the electrode array that is inserted sur-
gically into the cochlea. Electrode technology has evolved 
since the first cochlear implants were introduced in the 
early 1980s. Contemporary electrode designs are aimed 
at (1) limiting intracochlear damage during electrode 
insertion, and (2) reducing the current required for usa-
ble hearing [3].
The HiFocus Helix™ electrode [4] (Advanced Bion-
ics LLC, USA) addresses the first two of those aims. Its 
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perimodiolar design places the stimulating contacts near 
the spiral ganglion cells in the cochlear modiolus. Prox-
imity to the ganglion spiral cells is expected to provide 
better stimulation at lower current levels, thus resulting 
in lower power requirements.
Several studies have shown that the HiFocus Helix™ 
meets its design goals. A temporal bone study was con-
ducted to analyze a prototype of the Helix II™ electrode 
[5]. The Helix II™ was shown to have a 436-degree inser-
tion angle and cochlear medial wall positioning. No evi-
dence of inner ear trauma in the temporal bones was 
identified. A prospective CT-scan analysis of 39 HiFocus 
Helix™ electrode recipients showed correct placement of 
the electrode into scala tympani in 100% of cases when 
utilizing an electrode insertion tool and in 85.7% of cases 
without the insertion tool [6].
The aim of this study is to describe the first insertion 
of a HiFocus Helix™ electrode in Brazil. Surgical particu-
larities, device details, and its benefits are discussed.
Case presentation
This article is based on the description of the surgical 
technique of pre-curved electrode insertion (Advanced 
Bionics HiFocus Helix™). Medical records of the 
patient selected as well as a review of the literature were 
analysed.
Device
The HiResolution™ Bionic Ear cochlear implant sys-
tem (Advanced Bionics LLC, USA) was selected for this 
patient. It was used the HiRes 90K™ implant with HiFo-
cus Helix™ electrode implantable components (Figure 1). 
The HiFocus Helix™ electrode is a highly pre-curved 
device that is designed for close perimodiolar placement. 
It has a total length of 24.5 mm with 16 stimulating con-
tacts that face the modiolar wall for highly focused and 
selective stimulation of the spiral ganglion cells (Fig-
ure  2). The HiFocus Helix™ is intended to be inserted 
360°–430° into the cochlea using a cochleostomy of 1.2–
1.6 mm (Advanced Bionics).
Subject
The patient was a 17-year-old female referred to our 
hospital for the evaluation of candidacy for a cochlear 
implant. Her hearing loss was diagnosed at the age of 
5 years and the patient began using bilateral hearing aid 
1  year later. There were no abnormalities observed at a 
physical examination.
High resolution temporal bone CT and MRI stud-
ies detected cochlear malformation and large vestibular 
aqueduct in both sides, thus characterizing Mondini dys-
plasia (Figure 3).
Before surgery, the patient was informed about the sur-
gical procedure, implant device, post-operative expecta-
tions, and possible complications.
Surgical technique
The HiRes 90K™ implant and HiFocus Helix™ elec-
trode were surgically implanted using manufacturer-
recommended techniques and procedures (Advanced 
Bionics). Facial nerve function was monitored during 
surgery using the Xomed-Treace Nerve Integrity Moni-
tor-2 (NIM 2™). The monitoring electrodes were placed 
in the frontal and zygomatic areas. No problems were 
Figure 1 HiFocus Helix electrodes (from HiFocus Helix electrode 
surgical guide). Permission to republish images granted by copyright 
holders Advanced Bionics.
Figure 2 Measurements of HiFocus Helix electrode (from HiFocus 
Helix electrode surgical guide). Permission to republish images 
granted by copyright holders Advanced Bionics.
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encountered during surgery and no complications 
occurred.
The patient was under general anesthesia and placed 
in supine position. Antibiotic prophylaxis (Cefazolin 1 g) 
was administered intravenously. The surgical steps are 
described below:
 1. Antisepsis of the entire face and retroauricular 
region;
 2. Retroauricular trichotomy, micropore tape used to 
isolate this region;
 3. Local anesthesia (Lidocaine 2% with epinephrine, 
applied dosage of 4% mg lidocaine/kg) in retroauric-
ular area;
 4. New antisepsis of the mentioned regions;
 5. Placement of sterile sheets in retroauricular areas;
 6. Rectilinear retroauricular incision of approximately 
4 cm and dissection along anatomical places; prepa-
ration of a cross-like muscle-periosteal flap;
 7. Removal of small fragments of fascia and temporal 
muscle to occlude the cochleostomy;
 8. Simple mastoidectomy, identifying the lateral semicircu-
lar canal, the short process of the incus, the posterior 
wall of the outer ear canal, tegmen tympani and the 
lateral sinus, gathering a small amount of bone dust;
 9. Thinning of the posterior wall of the outer ear canal, 
posterior tympanotomy with preservation of the 
incus buttress;
 10. After identification of the round window niche, a 
1.5  mm cochleostomy is created antero-inferior to 
the round window;
 11. Placement of internal part of the device in a peri-
osteal pocket created in the squamous part of the 
temporal bone;
 12. Insertion of the electrode into the cochleostomy 
using and electrode inserter;
 13. Positioning the muscle graft around the electrode to 
seal the cochleostomy; placing bone dust to close the 
posterior tympanotomy;
 14. Closure with Vycril 3.0 sutures on the muscle-peri-
osteum flap and subcutaneous tissue; skin closure 
with Nylon 4.0;
Figure 3 CT scan, axial section, there is an enlarged vestibular aqueduct and malformation of the cochlea, corresponding to Mondini dysplasia in 
both sides.
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 15. Cleaning of the patient and external compressive 
dressing;
 16. Impedance testing, neural response imaging (NRI) 
and a transorbital incidence radiograph to confirm 
intracochlear position of the electrode (Figures 4, 5).
Results
We experienced no problem during the electrode inser-
tion and we observed an improvement in hearing thresh-
olds and speech perception of the patient.
Conclusion
As cochlear implantation benefits have been well estab-
lished, a new focus has been directed to better perfor-
mance devices combined with less trauma to the inner 
ear. In this concept, the Helix model was created using a 
perimodiolar positioning that would provide better neu-
ral stimulation [4–8].
First perimodiolar electrodes were introduced 12 years 
ago, and can be either curved or designed to curve at 
itself during insertion. Proximity to the ganglion spiral 
cells is sought to provide better stimulation at lower cur-
rent levels, thus leading to less cochlear damage and less 
energy consumption [4–8].
A temporal bone anatomic study was conducted to 
analyze prototypes of models Thin Lateral™ and Helix 
II™ (Advanced Bionics Corporation). The study observed 
a medium depth of insertion of 368 and cochlear lateral 
wall positioning in the Thin Lateral™ model. Helix II™ 
was shown to have a 436 insertion and cochlear medial 
wall positioning. No evidence of inner ear trauma in 
the temporal bones was identified for both devices. The 
lesser diameter in these devices compared to conven-
tional electrodes seems to contribute to performance and 
less cochlear trauma [5, 6].
The curved shape and lateral flexibility of the Thin 
Lateral™ device allows the bundle of electrodes to 
follow the cochlear lateral wall curvature, therefore 
avoiding damage and risk of tympanic scale manipula-
tion [6, 8].
Figure 4 Insertion method of the HiFocus Helix electrode (from HiFocus Helix electrode surgical guide). Permission to republish images granted by 
copyright holders Advanced Bionics.
Figure 5 Post-operative transorbital X-Ray. Observe the positioned electrode inside the left cochlea.
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The Helix II™ model has an insertor that is removed 
during insertion allowing the bundle of electrodes to 
curve medially along the tympanic scale, diminishing the 
risk of trauma to the spiral ligament [6].
Another prospective analysis with 82 patients aged 
between 18 and 84  years fitted with devices Nucleus® 
Freedom™ RECA (Cochlear®) and Advanced Bionics 
HiRes 90K™ HiFocus Helix™ (Advanced Bionics) showed 
a correct positioning of the electrodes through com-
puted tomography in 95.1% of the cases. All cases were 
implanted via round window with or without an inser-
tor. The radiologic confirmation of the electrode position 
inside the tympanic scale was obtained in 95.4% of cases 
fitted with Nucleus® Freedom™ device. The Helix 90k™ 
device showed correct placement in 100% of cases when 
utilizing an electrode insertor and 85.7% without the 
insertor [5].
The perimodiolar HiFocus Helix™ electrode proved 
easy to insert in this patient. In addition, the recipient 
was able to experience better hearing thresholds and 
improved speech perception compared to pre-operatively 
with a hearing aid. Thus, the HiFocus Helix™ electrode is 
a viable and effective electrode option for patients who 
choose a HiResolution™ Bionic Ear.
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